420
Views
42
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Provigil (Modafinil) Plus Cognitive Behavioral Therapy for Methamphetamine Use in HIV+ Gay Men: A Pilot Study

, , &
Pages 34-37 | Published online: 21 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Jack Donlon, Pooja Kumari, Sajoy P. Varghese, Michael Bai, Ori David Florentin, Emma D. Frost, John Banks, Niyathi Vadlapatla, Olivia Kam, Mujeeb U. Shad, Shafiqur Rahman, Osama A. Abulseoud, Trevor W. Stone & Maju Mathew Koola. (2024) Integrative Pharmacology in the Treatment of Substance Use Disorders. Journal of Dual Diagnosis 20:2, pages 132-177.
Read now
Daniel Turner, Peer Briken, Joshua Grubbs, Leo Malandain, Gemma Mestre-Bach, Marc N. Potenza & Florence Thibaut. (2022) The World Federation of Societies of Biological Psychiatry guidelines on the assessment and pharmacological treatment of compulsive sexual behaviour disorder. Dialogues in Clinical Neuroscience 24:1, pages 10-69.
Read now
Christopher D Verrico, Colin N Haile, Thomas F Newton, Thomas R Kosten & Richard De La Garza. (2013) Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications. Expert Opinion on Investigational Drugs 22:12, pages 1549-1568.
Read now
Sadmir Ciketic, Mohammad R. Hayatbakhsh, Chris M. Doran, Jake M. Najman & Rebecca McKetin. (2012) A review of psychological and pharmacological treatment options for methamphetamine dependence. Journal of Substance Use 17:4, pages 363-383.
Read now

Articles from other publishers (38)

Melinda Hersey & Gianluigi Tanda. 2024. Pharmacological Advances in Central Nervous System Stimulants. Pharmacological Advances in Central Nervous System Stimulants 287 326 .
Don Leidl, Pearl Takhar & Hua Li. (2023) Prescription psychostimulants as a harm reduction and treatment intervention for methamphetamine use disorder and the implications for nursing clinical practice: A scoping review of the literature. International Journal of Mental Health Nursing 32:5, pages 1225-1242.
Crossref
Megan M. St. Peters, Chun Hui J. Park, Alyna Turner, Alexandre A. Guerin & Jee Hyun Kim. (2023) Past and current drug repurposing clinical trials to treat cognition in methamphetamine use: a scoping review of pharmacotherapy candidates. Addiction Neuroscience 5, pages 100064.
Crossref
Jeremy D. Kidd, Margaret M. Paschen-Wolff, Amy A. Mericle, Billy A. Caceres, Laurie A. Drabble & Tonda L. Hughes. (2022) A scoping review of alcohol, tobacco, and other drug use treatment interventions for sexual and gender minority populations. Journal of Substance Abuse Treatment 133, pages 108539.
Crossref
Jessica F. Magidson, Jennifer M. Belus, C. J. Seitz-Brown, Hannah Tralka, Steven A. Safren & Stacey B. Daughters. (2021) Act Healthy: A Randomized Clinical Trial Evaluating a Behavioral Activation Intervention to Address Substance Use and Medication Adherence Among Low-Income, Black/African American Individuals Living with HIV/AIDS. AIDS and Behavior 26:1, pages 102-115.
Crossref
Christine Yuodelis-Flores, Matthew Iles-Shih & Richard K. Ries. 2022. Textbook of Community Psychiatry. Textbook of Community Psychiatry 331 349 .
Melinda Hersey, Amanda K. Bacon, Lydia G. Bailey, Mark A. Coggiano, Amy H. Newman, Lorenzo Leggio & Gianluigi Tanda. (2021) Psychostimulant Use Disorder, an Unmet Therapeutic Goal: Can Modafinil Narrow the Gap?. Frontiers in Neuroscience 15.
Crossref
Alyssa Hickert, Benjamin Rowley & Marley Doyle. (2021) Perinatal Methamphetamine Use: A Review of the Literature. Psychiatric Annals 51:4, pages 189-197.
Crossref
Jinny Claire Lee & Kim D. Janda. (2021) Immunopharmacotherapeutic advancements in addressing methamphetamine abuse. RSC Chemical Biology 2:1, pages 77-93.
Crossref
Ahmed Elkashef & Jag H. Khalsa. 2021. Textbook of Addiction Treatment. Textbook of Addiction Treatment 187 195 .
Heather Palis, Scott Harrison, Scott MacDonald, David C. Marsh, Martin T. Schechter & Eugenia Oviedo‐Joekes. (2020) Self‐managing illicit stimulant use: A qualitative study with patients receiving injectable opioid agonist treatment. Drug and Alcohol Review 39:7, pages 914-923.
Crossref
Hannah Khoddam & David K. Wellisch. (2019) Psychological Distress in Hospitalized Patients Awaiting Organ Transplantation: Case Examples, Thematic Exploration, and Suggestions for Intervention. Journal of Clinical Psychology in Medical Settings 27:3, pages 622-631.
Crossref
Yu-Te HuangYuk Tung MaShelley L. CraigDaniel Fu Keung WongMarty W. Forth. (2020) How Intersectional Are Mental Health Interventions for Sexual Minority People? A Systematic Review. LGBT Health 7:5, pages 220-236.
Crossref
Erik D. Storholm, Laura M. Bogart, Matt G. Mutchler, David J. Klein, Bonnie Ghosh-Dastidar, Bryce McDavitt & Glenn J. Wagner. (2018) Antiretroviral Adherence Trajectories Among Black Americans Living with HIV. AIDS and Behavior 23:8, pages 1985-1997.
Crossref
Rod Knight, Mohammad Karamouzian, Anna Carson, Joshua Edward, Patrizia Carrieri, Jean Shoveller, Nadia Fairbairn, Evan Wood & Danya Fast. (2019) Interventions to address substance use and sexual risk among gay, bisexual and other men who have sex with men who use methamphetamine: A systematic review. Drug and Alcohol Dependence 194, pages 410-429.
Crossref
Mariana Schmajuk, Earl DeGuzman & Nicole Allen. 2019. Psychosocial Care of End-Stage Organ Disease and Transplant Patients. Psychosocial Care of End-Stage Organ Disease and Transplant Patients 471 481 .
Nicole K. Lee, Linda Jenner, Angela Harney & Jacqui Cameron. (2018) Pharmacotherapy for amphetamine dependence: A systematic review. Drug and Alcohol Dependence 191, pages 309-337.
Crossref
Taryn M. Park & William F. HaningIIIIII. (2016) Stimulant Use Disorders. Child and Adolescent Psychiatric Clinics of North America 25:3, pages 461-471.
Crossref
Dan-Ni Cao, Jing-Jing Shi, Wei Hao, Ning Wu & Jin Li. (2016) Advances and challenges in pharmacotherapeutics for amphetamine-type stimulants addiction. European Journal of Pharmacology 780, pages 129-135.
Crossref
Kelly E. Courtney & Lara A. Ray. 2016. Neuroscience for Addiction Medicine: From Prevention to Rehabilitation - Constructs and Drugs. Neuroscience for Addiction Medicine: From Prevention to Rehabilitation - Constructs and Drugs 295 310 .
Andrew C. McCreary, Christian P. Müller & Małgorzata Filip. 2015. The Neuropsychiatric Complications of Stimulant Abuse. The Neuropsychiatric Complications of Stimulant Abuse 41 83 .
Ahmed Elkashef. 2015. Textbook of Addiction Treatment: International Perspectives. Textbook of Addiction Treatment: International Perspectives 405 414 .
Kelly E. Courtney & Lara A. Ray. (2014) Methamphetamine: An update on epidemiology, pharmacology, clinical phenomenology, and treatment literature. Drug and Alcohol Dependence 143, pages 11-21.
Crossref
Ariadna Forray & Mehmet Sofuoglu. (2014) Future pharmacological treatments for substance use disorders. British Journal of Clinical Pharmacology 77:2, pages 382-400.
Crossref
Christopher D. Verrico, James J. Mahoney, Daisy G. Y. Thompson-Lake, Ryan S. Bennett, Thomas F. Newton & Richard De La Garza. (2014) Safety and efficacy of varenicline to reduce positive subjective effects produced by methamphetamine in methamphetamine-dependent volunteers. The International Journal of Neuropsychopharmacology 17:02, pages 223-233.
Crossref
Colin N. Haile & Thomas R. Kosten. (2013) Pharmacotherapy for Stimulant-Related Disorders. Current Psychiatry Reports 15:11.
Crossref
Matthew Brensilver, Keith G. Heinzerling & Steven Shoptaw. (2013) Pharmacotherapy of amphetamine‐type stimulant dependence: An update. Drug and Alcohol Review 32:5, pages 449-460.
Crossref
Gabriel S Dichter, Cara A Damiano & John A Allen. (2012) Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings. Journal of Neurodevelopmental Disorders 4:1.
Crossref
Radha RajasinghamMatthew J. MimiagaJaclyn M. WhiteMegan M. PinkstonRachel P. BadenJennifer A. Mitty. (2012) A Systematic Review of Behavioral and Treatment Outcome Studies Among HIV-Infected Men Who Have Sex with Men Who Abuse Crystal Methamphetamine. AIDS Patient Care and STDs 26:1, pages 36-52.
Crossref
Christine Yuodelis-Flores, Richard K. Ries & W. Murray Bennett. 2012. Handbook of Community Psychiatry. Handbook of Community Psychiatry 277 292 .
Mascha Nuijten, Peter Blanken, Wim van den Brink & Vincent Hendriks. (2011) Cocaine Addiction Treatments to improve Control and reduce Harm (CATCH): New Pharmacological Treatment Options for Crack-Cocaine Dependence in the Netherlands. BMC Psychiatry 11:1.
Crossref
Adam Gonzalez, Jennifer Barinas & Conall O’Cleirigh. (2011) Substance Use: Impact on Adherence and HIV Medical Treatment. Current HIV/AIDS Reports 8:4, pages 223-234.
Crossref
Crystal C. Watkins, Andrew A. Pieper & Glenn J. Treisman. (2011) Safety Considerations in Drug Treatment of Depression in HIV-Positive Patients. Drug Safety 34:8, pages 623-639.
Crossref
Laurent Karila, Aviv Weinstein, Henri‐Jean Aubin, Amine Benyamina, Michel Reynaud & Steven L. Batki. (2010) Pharmacological approaches to methamphetamine dependence: a focused review. British Journal of Clinical Pharmacology 69:6, pages 578-592.
Crossref
Brian J Dew. (2010) Toward a Better Understanding of Non-Addicted, Methamphetamine-Using, Men who Have Sex with Men (MSM) in Atlanta. The Open AIDS Journal 4:1, pages 141-147.
Crossref
David V. Herin, Craig. R. Rush & John Grabowski. (2010) Agonist‐like pharmacotherapy for stimulant dependence: preclinical, human laboratory, and clinical studies. Annals of the New York Academy of Sciences 1187:1, pages 76-100.
Crossref
Richard De La GarzaIIII, Todd Zorick, Edythe D. London & Thomas F. Newton. (2010) Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers. Drug and Alcohol Dependence 106:2-3, pages 173-180.
Crossref
Janette McGaugh, Michael J. Mancino, Zachary Feldman, Mohit P. Chopra, W. Brooks Gentry, Christopher Cargile & Alison Oliveto. (2009) Open-Label Pilot Study of Modafinil for Methamphetamine Dependence. Journal of Clinical Psychopharmacology 29:5, pages 488-491.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.